Id: | acc3385 |
Group: | 2sens |
Protein: | HSA |
Gene Symbol: | ALB |
Protein Id: | P02768 |
Protein Name: | ALBU_HUMAN |
PTM: | glycosylation |
Site: | unclear |
Site Sequence: | |
Disease Category: | Endocrine and metabolic diseases |
Disease: | Hyperglycemia |
Disease Subtype: | |
Disease Cellline: | |
Disease Info: | |
Drug: | tolbutamide |
Drug Info: | Tolbutamide is an oral hypoglycemic drug used to treat type 2 diabetes by stimulating the pancreas to produce more insulin. |
Effect: | decrease |
Effect Info: | "Glycation increases the affinity of TB and LOS for albumin and affects their interaction, that is, glycation of HSA reduces the efficacy of the drugs." |
Note: | |
Score: | 5.0 |
Pubmed(PMID): | 29258218 |
Sentence Index: | 29258218_7-8 |
Sentence: | "Changes in binding parameters, such as association ( K a ) or Stern-Volmer ( K S V ) constants suggest that glycation increases the affinity of TB and LOS towards albumin and affects interactions between them. The process of albumin glycation influences the pharmacokinetics of drugs, thus monitored pharmacotherapy is reasonable in the case of diabetes and hypertension polypharmacy." |
Sequence & Structure:
MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL
Select PDB:
No data.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.